RPRX vs WBD · P/E 15, rev $1.30B vs rev $17.61B
Royalty Pharma Plc (RPRX) versus Warner Bros Discovery Inc (WBD) — a side-by-side from cached financials, not a winner call.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Warner Bros Discovery Inc (WBD) is a entertainment company listed on NASDAQ.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Latest reported WBD revenue for 2026-06-30 was $17.61B. Net income was -$2.77B. Revenue was up 98.0% from 2026-03-31 to 2026-06-30. WBD currently screens at market cap $66.93B.
RPRX currently screens at market cap $20.45B and trailing P/E 14.8. WBD currently screens at market cap $66.93B.
Not investment advice. Open the RPRX and WBD stock pages for the full models.
Not investment advice.